Findings
What do systematic reviews say? 4,776 questions · 7,311 findings · 959 reviews · Headline outcomes only
No studies found 1,498 · 20.5% GRADE not reported 303 · 4.1% Very low 1,839 · 25.2% Low 1,991 · 27.2% Moderate 1,277 · 17.5% High 403 · 5.5%
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Quality of life · men with benign prostatic hyperplasia
1 finding from 1 review
Major adverse events · men with benign prostatic hyperplasia
It is very uncertain whether aquablation changes major adverse events compared with transurethral resection of the prostate (very low certainty).
1 finding from 1 review
Retreatment · men with benign prostatic hyperplasia
It is very uncertain whether aquablation changes retreatment compared with transurethral resection of the prostate (very low certainty).
1 finding from 1 review
Erectile function · men with benign prostatic hyperplasia
1 finding from 1 review
Ejaculatory function · men with benign prostatic hyperplasia
1 finding from 1 review
Intervention not reported Success of prosthetic rehabilitation (preference) (1 day) · adults over the age of 50 with a unilateral transfemoral amputation
1 finding from 1 review
Intervention not reported Adverse effects (1 day) · adults over the age of 50 with a unilateral transfemoral amputation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Urological symptom scores
1 finding from 1 review
Sexual adverse events
Naftopidil probably leads to lower sexual adverse events compared with silodosin (alpha‐blocker) (moderate certainty).
1 finding from 1 review
Urological symptom scores
1 finding from 1 review
Quality of life
1 finding from 1 review
Treatment withdrawal
1 finding from 1 review
Cardiovascular adverse events
1 finding from 1 review
Sexual adverse events
1 finding from 1 review
Urological symptom scores
1 finding from 1 review
Quality of life
1 finding from 1 review
Treatment withdrawal
It is very uncertain whether naftopidil changes treatment withdrawals for any reason compared with eviprostat (phytotherapy) (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events
It is very uncertain whether naftopidil changes treatment withdrawals due to adverse events compared with eviprostat (phytotherapy) (very low certainty).
1 finding from 1 review
Quality of life
1 finding from 1 review
Cardiovascular adverse events
1 finding from 1 review
evidence gaps · evidencegaps.com
Not clinical guidance. Data from the Cochrane Library (Summary of Findings tables and full text), PubMed and Crossref, extracted by the Evidence Gaps pipeline. Related-question groupings and the gap map key are proposals pending human validation. A review that found no studies, or no review at all, is not proof that no research exists.